AIMC Topic: Drug Discovery

Clear Filters Showing 681 to 690 of 1689 articles

Targeting protein-protein interactions with low molecular weight and short peptide modulators: insights on disease pathways and starting points for drug discovery.

Expert opinion on drug discovery
INTRODUCTION: Protein-protein interactions (PPIs) have been often considered undruggable targets although they are attractive for the discovery of new therapeutics. The spread of artificial intelligence and machine learning complemented with experime...

The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery.

British journal of pharmacology
The application of artificial intelligence (AI) approaches to drug discovery for G protein-coupled receptors (GPCRs) is a rapidly expanding area. Artificial intelligence can be used at multiple stages during the drug discovery process, from aiding ou...

Artifical intelligence: a virtual chemist for natural product drug discovery.

Journal of biomolecular structure & dynamics
Nature is full of a bundle of medicinal substances and its product perceived as a prerogative structure to collaborate with protein drug targets. The natural product's (NPs) structure heterogeneity and eccentric characteristics inspired scientists to...

Prospective Validation of Machine Learning Algorithms for Absorption, Distribution, Metabolism, and Excretion Prediction: An Industrial Perspective.

Journal of chemical information and modeling
Absorption, distribution, metabolism, and excretion (ADME), which collectively define the concentration profile of a drug at the site of action, are of critical importance to the success of a drug candidate. Recent advances in machine learning algori...

Using a stacked ensemble learning framework to predict modulators of protein-protein interactions.

Computers in biology and medicine
Identifying small molecule protein-protein interaction modulators (PPIMs) is a highly promising and meaningful research direction for drug discovery, cancer treatment, and other fields. In this study, we developed a stacking ensemble computational fr...

Molecular Generation with Reduced Labeling through Constraint Architecture.

Journal of chemical information and modeling
In the past few years, a number of machine learning (ML)-based molecular generative models have been proposed for generating molecules with desirable properties, but they all require a large amount of label data of pharmacological and physicochemical...

From jeopardy champion to drug discovery; semantic similarity artificial intelligence.

Autophagy
We have employed artificial intelligence to streamline the small molecule drug screening pipeline and identified the cholesterol-reducing compound probucol in the process. Probucol augmented mitophagy and prevented loss of dopaminergic neurons in fli...

MD-GNN: A mechanism-data-driven graph neural network for molecular properties prediction and new material discovery.

Journal of molecular graphics & modelling
Molecular properties prediction and new material discovery are significant for the pharmaceutical industry, food, chemistry, and other fields. The popular methods are theoretical mechanism calculation and machine learning. There is a deviation betwee...

Protein model quality assessment using rotation-equivariant transformations on point clouds.

Proteins
Machine learning research concerning protein structure has seen a surge in popularity over the last years with promising advances for basic science and drug discovery. Working with macromolecular structure in a machine learning context requires an ad...

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease.

International journal of molecular sciences
Over the past three years, significant progress has been made in the development of novel promising drug candidates against COVID-19. However, SARS-CoV-2 mutations resulting in the emergence of new viral strains that can be resistant to the drugs use...